ID
24753
Description
Study ID: 100470 Clinical Study ID: SCO100470 Study Title: A multicentre, randomised, double-blind, parallel group, 24 week study to compare the effect of salmeterol/fluticasone propionate combination product 50/250mcg, with salmeterol 50mcg both delivered twice daily via DISKUS®/ACCUHALER® inhaler on lung function and dyspnoea in subjects with Chronic Obstructive Pulmonary Disease (COPD). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone propionate/salmeterol Trade Name: Serevent Study Indication: Pulmonary Disease, Chronic Obstructive
Keywords
Versions (3)
- 8/16/17 8/16/17 -
- 8/16/17 8/16/17 -
- 8/16/17 8/16/17 -
Uploaded on
August 16, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
daily record card administration salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470
daily record card administration salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470
Description
Next Clinic Visit
Alias
- UMLS CUI-1
- C0008952 (Clinic Visits)
Description
date of next clinic visit
Data type
date
Alias
- UMLS CUI [1]
- C2735342 (Date next clinic visit)
- LOINC
- LP96939-1
Description
time of next clinic visit
Data type
time
Alias
- UMLS CUI [1,1]
- C0008952 (Clinic Visits)
- UMLS CUI [1,2]
- C0040223 (Time)
- SNOMED
- 410670007
- LOINC
- LP73517-2
Similar models
daily record card administration salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470
C0920316 (UMLS CUI [1,2])
C1442065 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
No comments